Table 1.
Clinical characteristics (n.28)
Variable | |
---|---|
Age (mean ± SD) (years) | 61.7 ± 10 |
Men | 22 (79%) |
BMI (mean ± SD) (kg/m2) | 28.4 ± 5 |
BMI ≥ 28 | 17 (60.7%) |
Risk factors | |
Smoker | 21 (75%) |
Hypertension | 25 (89%) |
Diabetes mellitus | 11 (39%) |
Ischemic heart disease | 8 (28.6%) |
Chronic renal failure | 1 (3.5%) |
COPD | 2 (7%) |
Mechanical ventilation | 24 (86%) |
Veno-venous ECMO | 4 (14%) |
ICU death | 2 (7%) |
Laboratory findings | |
Creatinine (mg/dl) (mean ± SD) | 1.08 ± 0.5 |
ALT (U/L) (median, range) | 28 (9–205) |
LDH (U/L) (median, range) | 379 (200–1900) |
NT pro BNP (pg/ml) (median, range) | 390 (56–12800) |
Procalcitonin (pg/ml) (median, range) | 0.24 (0.06–9) |
Interleukin-6 (pg/ml) (median, range) | 66 (4–354) |
Interleukin – 6 > 40 ng/ml (n.%) | 20 (71%) |
D-dimer (ng/ml) (median, range) | 1571 (513–55758) |
Troponin T (median, range) | |
Admission | 17 (8–180) |
Peak | 32 (8–253) |
C-Reactive protein | |
Admission | 175 (5–760) |
Peak | 241 (5–780) |
ALT = Alanine transaminase; COPD = chronic obstructive pulmonary disease; ECMO = extra corporeal membrane oxygenation; ICU = intensive care unit; , LDH = Lactose dehydrogenase; NT-BNP = N terminal Brain Natriuretic Peptide; SD = standard deviation.